A principal partner of QiC Excellence in Oncology

A major partner of QiC Excellence in Oncology.
“Bristol-Myers Squibb are delighted to support the Quality in Care Excellence in Oncology Initiative. There are many examples of excellent and innovative care throughout the NHS. This initiative provides an opportunity to highlight these areas of good practice and to share this work more widely to continue to drive quality and innovation.”
Martin Whitehead, Bristol-Myers Squibb
National Policy and Access Manager, Oncology

A major partner of QiC Excellence in Oncology.
“The Nicholson review has recognised the failure to identify and celebrate good practice as a major barrier to innovation. The QiC awards provide an excellent opportunity to address this barrier in the area of cancer. Novartis is particularly keen for the programme to go beyond merely celebrating success by actively promoting and supporting the implementation of good practice in parts of the NHS that would benefit from service improvements. It is this step that will result in tangible benefits for patients and that is a key element in our decision to sponsor the project.”
Barbara Mclaughlan, Novartis
National Cancer Policy Lead

Beating Bowel Cancer

“Individuals and teams from across the whole spectrum of our healthcare community are making real progress in improving the patient’s experience of a cancer journey, with innovative, effective changes and improvements in the way they work. Beating Bowel Cancer believes that QiC Excellence in Oncology will provide a much needed platform to promote their work to a wider audience and set the benchmark for others to aspire to.”
Lilian Wiles, Beating Bowel Cancer
Head of Patient Services

Macmillan Cancer Support

"Macmillan Cancer Support aims to support people with cancer every step of the way and push for better cancer care. We are delighted to support the Quality in Care Oncology programme which will identify and share good practice and help to spread the expertise and knowledge of successful innovations."
Jenny Ritchie-Campbell, Cancer Services Innovation
Director 

Celgene

GlaxoSmithKline

Roche

Eisai

The Roy Castle Lung Cancer Foundation

"I have been privileged to be a judge for Pfizer’s 'Excellence in Oncology Awards' in recent years and am sure that the QiC Oncology initiative will be a natural progression and extension of this. Promoting and extending quality initiatives in this way will undoubtedly benefit future cancer services and care."
Jesme Fox, Roy Castle Lung Cancer Foundation
Medical Director

Cancer 52